Skip to Content

XL184 80mg (Cometriq 80 mg)

Generic Name: cabozantinib

Pill imprint XL184 80mg has been identified as Cometriq 80 mg.

Cometriq is used in the treatment of thyroid cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Cometriq 80 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cometriq
Generic Name:
cabozantinib
Imprint:
XL184 80mg
Strength:
80 mg
Color:
Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Exelixis, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide